| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $67.7M | +16.9% |
| R&D Expense | $388.9M | -16.6% |
| SG&A Expense | $119.8M | -4.8% |
| Operating Income | -$441.0M | +17.5% |
| Income Tax | $0 | — |
| Net Income | -$412.7M | +20.5% |
| EPS (Basic) | -$3.81 | +27.4% |
| EPS (Diluted) | -$3.81 | +27.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $155.5M | -17.8% |
| Short-term Investments | $294.4M | -28.6% |
| Accounts Receivable | $9.5M | +11.2% |
| Current Assets | $527.7M | -17.5% |
| Total Assets | $842.1M | -29.3% |
| Current Liabilities | $103.9M | -6.3% |
| Total Liabilities | $170.7M | -46.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$394.7M | -13.1% |
| Capital Expenditures | $1.1M | -80.5% |
| Investing Cash Flow | $228.0M | +81.6% |
| Financing Cash Flow | $131.5M | -29.2% |
| Free Cash Flow | -$395.9M | -11.6% |
| Stockholders' Equity |
| $671.4M |
| -23.0% |